Man pages for InnovationValueInitiative/IVI-RA
The IVI-RA model
| acr2cdai | Change in CDAI by 6-month ACR response |
| acr2das28 | Change in DAS28 by 6-month ACR response |
| acr2eular | ACR to EULAR Conversion |
| acr2haq | HAQ change by 6-month ACR response |
| acr2sdai | Change in SDAI by 6-month ACR response |
| check_lifetable | Check lifetable |
| check_matrix | Check matrix |
| check_nma_k | Check NMA effect reduction |
| check_scalar | Check scalar |
| check_sim_qalys | Check parameters of sim_qalys |
| check_sim_utility_mixture | Check parameters of sim_utility_mixture |
| check_sim_utility_wailoo | Check parameters of sim_utility_wailoo |
| check_ttd | Check time to discontinuation |
| check_vector | Check vector |
| eular2haq | HAQ change by 6-month EULAR Response |
| get_input_data | Input data for simulation |
| haq.lcgm | Latent Class Growth Model (LCGM) for HAQ progression |
| haq.lprog | Linear HAQ progression rates |
| hosp.cost | Hospitalization costs |
| incidence | Incidence |
| iviRA | iviRA: an R package for running the IVI-RA model |
| lifetable | US Lifetables 2011 |
| lt_pars | Lifetable for simulation |
| mgmt.cost | Cost of general management of RA |
| mom_beta | Method of moments for beta Distribution |
| mom_gamma | Method of moments for gamma Distribution |
| mort.hr.haqdif | Mortality hazard ratio for change in HAQ score |
| mort.or | Mortality odds ratios by patient characteristics |
| nma | NMA estimates |
| nma_acrprob | ACR response probabilities |
| nma_lm_dy | NMA parameters to change in continuous outcome |
| pain | Correlation between HAQ and pain |
| prod.loss | Productivity loss |
| sample_betas | Sample from beta distributions |
| sample_dirichlets | Sample matrices using a Dirichlet distribution |
| sample_gammas | Sample from gamma distributions |
| sample_mvnorm | Sample from a multivariate normal distribution |
| sample_nma_acr | Sample ACR response from ordered probit NMA |
| sample_nma_lm | Sample from Bayesian linear model |
| sample_normals | Sample from normal distributions |
| sample_pars | Sample parameters |
| sample_pars_haq_lcgm | Sample parameters for the LCGM |
| sample_pars_utility_mixture | Utility mixture model parameters |
| sample_pop | Sample a patient population |
| sample_rtmvnorm_da | Sample disease activity levels and HAQ |
| sample_stratified_survpars | Sample stratified survival parameters |
| sample_survpars | Sample survival parameters |
| sample_uniforms | Sample from uniform distributions |
| select_model_structures | Select model structures |
| sim_dhaq6 | Simulate change in HAQ at 6 months |
| sim_iviRA | The IVI-RA simulation |
| sim_survtime | Simulate survival time for RA patients |
| sim_utility | Simulate utility after IPS |
| treatments | Treatments |
| ttd | Time to treatment discontinuation parameters |
| ttsi | Time to serious infection parameters |
| tx.cost | Treatment costs |
| utility.mixture | Mixture model utility mapping |
| utility.tx.attr | Treatment attributes |
| utility.wailoo | Wailoo (2006) utility mapping |
